))
This Week's Headlines: August 2, 2021
Manage episode 407440809 series 3560288
Content provided by Healio, Abhishek Bhardwaj, and MD. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Healio, Abhishek Bhardwaj, and MD or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
This week, Pfizer says a third dose of the vaccine boosts protection, even against the delta variant; US News and World Report ranks Mayo Clinic number 1 for pulmonology and lung surgery; the FDA approves IV selexipag for adults with PAH; and more.
Read the full coverage here:
Pfizer says third dose of vaccine boosts protection, including against delta variant
CDC alters mask guidance, says even vaccinated Americans need them in some places
Mayo Clinic ranked No. 1 hospital in US for pulmonology, lung surgery
FDA approves selexipag for IV use in adults with PAH
FDA approves Saphnelo, first new lupus treatment since 2011
References:
Lupus Research Alliance press release.
Pfizer. Second quarter 2021 earnings teleconference. July 28, 2021. https://s21.q4cdn.com/317678438/files/doc_financials/2021/q2/Q2-2021-Earnings-Charts-FINAL.pdf. Accessed on July 28, 2021.
Press Conference.
34 episodes
Share
